JP2024525760A5 - - Google Patents
Info
- Publication number
- JP2024525760A5 JP2024525760A5 JP2024501910A JP2024501910A JP2024525760A5 JP 2024525760 A5 JP2024525760 A5 JP 2024525760A5 JP 2024501910 A JP2024501910 A JP 2024501910A JP 2024501910 A JP2024501910 A JP 2024501910A JP 2024525760 A5 JP2024525760 A5 JP 2024525760A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- approximately
- patient
- migalastat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220816P | 2021-07-12 | 2021-07-12 | |
| US63/220,816 | 2021-07-12 | ||
| PCT/US2022/073626 WO2023288210A1 (en) | 2021-07-12 | 2022-07-12 | Methods of treating fabry disease in pediatric patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525760A JP2024525760A (ja) | 2024-07-12 |
| JP2024525760A5 true JP2024525760A5 (https=) | 2025-04-28 |
Family
ID=83149437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501910A Pending JP2024525760A (ja) | 2021-07-12 | 2022-07-12 | 小児患者のファブリー病を治療する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240293387A1 (https=) |
| EP (1) | EP4370120A1 (https=) |
| JP (1) | JP2024525760A (https=) |
| KR (1) | KR20240034203A (https=) |
| AU (1) | AU2022310691A1 (https=) |
| CA (1) | CA3225511A1 (https=) |
| WO (1) | WO2023288210A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220044560A (ko) | 2019-08-07 | 2022-04-08 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| MX2009010557A (es) | 2007-03-30 | 2009-11-19 | Amicus Therapeutics Inc | Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas. |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
-
2022
- 2022-07-12 CA CA3225511A patent/CA3225511A1/en active Pending
- 2022-07-12 JP JP2024501910A patent/JP2024525760A/ja active Pending
- 2022-07-12 WO PCT/US2022/073626 patent/WO2023288210A1/en not_active Ceased
- 2022-07-12 AU AU2022310691A patent/AU2022310691A1/en active Pending
- 2022-07-12 KR KR1020247003776A patent/KR20240034203A/ko active Pending
- 2022-07-12 US US18/578,483 patent/US20240293387A1/en active Pending
- 2022-07-12 EP EP22761857.6A patent/EP4370120A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| EP0397831B1 (en) | Treatment of obesity | |
| ES2797493T3 (es) | Formulaciones farmacéuticas de liberación controlada de nitazoxanida | |
| JPS6143112A (ja) | 精神性欲機能障害治療剤 | |
| RU2190401C2 (ru) | Средство для лечения воспалительных заболеваний кишечника | |
| JP2020531550A5 (https=) | ||
| US20070265343A1 (en) | Method for alleviating signs and symptoms of spasticity | |
| JP2021535107A5 (https=) | ||
| JP2023513700A5 (https=) | ||
| JP3018160B2 (ja) | 月経困難症及び／又は月経前症候群の軽減用薬剤 | |
| FI4103178T3 (fi) | Menetelmiä fabryn taudin hoitamiseksi | |
| CN102805746B (zh) | 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用 | |
| Plänitz | Comparison of moxonidine and clonidine HCl in treating patients with hypertension | |
| US5712259A (en) | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome | |
| US20080311196A1 (en) | All Day Rhinitic Condition Treatment Regimen | |
| JP2024525760A5 (https=) | ||
| JP2005512946A5 (https=) | ||
| JP2022553888A5 (https=) | ||
| Nugent et al. | Glucocorticoid toxicity: single contrasted with divided daily doses of prednisolone | |
| CA2612480A1 (en) | Tizanidine compositions and methods of treatment using the compositions | |
| PT891186E (pt) | Administração nasal de agentes para o tratamento de emese tardia | |
| CA3120920C (en) | Montelukast for the treatment of erosive hand osteoarthritis | |
| JP2022518733A5 (https=) | ||
| SI9620036B (sl) | Derivat aminotetralina za terapijo kardiovaskularnih bolezni | |
| TW200529847A (en) | Pharmaceutical composition for use in the treatment of chronic fatigue syndrome or fibromyalgia or associated functional symptoms of fibromyalgia |